Concepedia

Lida Pacaud

LP

43

Publications

8.6K

Citations

24

H-Index

2015

Active since

Affiliations

Janssen (United States)(Current)

University of Pennsylvania

University of Chicago

UPMC Hillman Cancer Center

UCSF Helen Diller Family Comprehensive Cancer Center

Lida Pacaud is an author at Janssen (United States) specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2015–2023

43

Publications

43

Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Stephen J. Schuster, Michael Bishop, Constantine S. Tam et al. · New England Journal of Medicine · 2018 · 3.9K citations · Full text

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study

James C. Yao, Nicola Fazio, Simron Singh et al. · The Lancet · 2015 · 1.2K citations

, , +8

Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma

Jesús F. San Miguel, Binod Dhakal, Kwee Yong et al. · New England Journal of Medicine · 2023 · 615 citations · Full text

Ciltacabtagene Autoleucel, an Anti–B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up

Thomas G. Martin, Saad Z. Usmani, Jesús G. Berdeja et al. · Journal of Clinical Oncology · 2022 · 580 citations · Full text

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

Marcelo C. Pasquini, Zhen‐Huan Hu, Kevin J. Curran et al. · Blood Advances · 2020 · 421 citations · Full text

Rows per page

1–5 of 43